Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca 2+ /Calmodulin-Dependent Kinase II-Reference-Cited by-同舟云学术

Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca 2+ /Calmodulin-Dependent Kinase II

Published:2019-07-30 Issue:5 Volume:140 Page:405-419
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Bezzerides Vassilios J.¹,Caballero Ana¹,Wang Suya¹,Ai Yulan¹,Hylind Robyn J.¹,Lu Fujian¹,Heims-Waldron Danielle A.¹,Chambers Kristina D.¹,Zhang Donghui¹,Abrams Dominic J.¹,Pu William T.¹²

Affiliation:

1. Basic and Translational Cardiovascular Research and Inherited Cardiac Arrhythmias Programs, Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, MA (V.J.B., A.C., S.W., Y.A., R.J.H., F.L., D.A.H.-W., K.D.C., D.Z., D.J.A., W.T.P.).

2. Harvard Stem Cell Institute, Cambridge, MA (W.T.P.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference51 articles.

1. Cardiac Channel Molecular Autopsy: Insights From 173 Consecutive Cases of Autopsy-Negative Sudden Unexplained Death Referred for Postmortem Genetic Testing

2. Catecholaminergic Polymorphic Ventricular Tachycardia in Children

3. Inherited calcium channelopathies in the pathophysiology of arrhythmias

4. Genetics of Sudden Cardiac Death

5. Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational research in pediatric cardiology;Nadas' Pediatric Cardiology;2025

2. Beyond the Beat: Understanding Inherited Risk and Therapeutic Opportunities in Cardiovascular Diseases with Emphasis on Inherited Cardiomyopathies and Inherited Arrhythmic Syndromes;Cardiogenetics;2024-09-02

3. Multi-Faceted Approach to Ventricular Tachycardia: A Review of Management Strategies;Pharmacoepidemiology;2024-08-12

4. Gene Therapy for Inherited Arrhythmia Syndromes;Cardiogenetics;2024-08-02

5. Ruxolitinib as a CaMKII inhibitor for treatment of cardiac arrhythmias: Applications and prospects;Heart Rhythm;2024-08